CIPLA:NSE
Cipla Ltd
၁,၃၃၁.၅၀ ₹
arrow_downward
-၀.၆၅%(-၈.၇၀) 1D
အောက် ၇, GMT+၅:၃၀ ၁၅:၃၀:၀၀ · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CIPLA...
Open
၁,၃၃၈.၅၀ ₹
High
၁,၃၅၁.၀၀ ₹
Low
၁,၃၂၄.၇၀ ₹
Mkt. cap
ဋေ ၁.၀၈ သိန်း
Avg. vol.
၉.၃၁ သိန်း
Volume
၈.၄၈ သိန်း
Dividend
၀.၉၈%
Quarterly dividend
၃.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇွန် ၅
P/E ratio
၃၁.၉၃
52-wk high
၁,၆၇၃.၀၀ ₹
52-wk low
၁,၁၆၅.၇၀ ₹
EPS
၄၁.၇၀ ₹
Shares outstanding
၈၀.၅၇ ကုဋေ
No. of employees
၃ သောင်း
Open
၁,၃၃၈.၅၀ ₹
High
၁,၃၅၁.၀၀ ₹
Low
၁,၃၂၄.၇၀ ₹
Mkt. cap
ဋေ ၁.၀၈ သိန်း
Avg. vol.
၉.၃၁ သိန်း
Volume
၈.၄၈ သိန်း
Dividend
၀.၉၈%
Quarterly dividend
၃.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇွန် ၅
P/E ratio
၃၁.၉၃
52-wk high
၁,၆၇၃.၀၀ ₹
52-wk low
၁,၁၆၅.၇၀ ₹
EPS
၄၁.၇၀ ₹
Shares outstanding
၈၀.၅၇ ကုဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
CNBC
·
ပြီးခဲ့သည့် ၁ နာရီ
Strange market anomaly is creating a buying opportunity in the Nasdaq 100
Newswire
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
FatPipe (NASDAQ: FATN) Refinances Existing Debt and Reduces Borrowing Costs
marketscreener.com
·
ပြီးခဲ့သည့် ၁ နာရီ
SMJ International Receives NYSE American Warning Over Delayed Disclosure of Executive Resignations
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees၃.၁၄ သောင်း
Founded၁၉၃၅
Headquartersမွမ်ဘိုင်းမြို့, မဟာရာရှ်ထရာ, အိန္ဒိယ
Sector-
Websitecipla.com